(Q38021305)

27 August 2017

The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication (English)

1 reference

27 August 2017

0 references

Julien Batisse

1

0 references

Santiago Guerrero

Santiago Guerrero

2

0 references

Carine Tisné

Carine Tisné

8

0 references

Jean-Christophe Paillart

Jean-Christophe Paillart

9

0 references

Roland Marquet

Roland Marquet

7

0 references

Serena Bernacchi

3

Serena Bernacchi

1 reference

27 August 2017

4

Dona Sleiman

1 reference

27 August 2017

Caroline Gabus

5

1 reference

PubMed ID

22728817

27 August 2017

Jean-Luc Darlix

6

1 reference

PubMed ID

22728817

27 August 2017

language of work or name

1 reference

21 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

169

1 reference

27 August 2017

2

1 reference

27 August 2017

361-376

1 reference

High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Host cell-dependent replication of HIV-1 mutants with deletions in gp41 cytoplasmic tail region is independent of the function of Vif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The HIV-1 Tat protein stimulates reverse transcription in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Paradigm development: comparative and predictive 3D modeling of HIV-1 Virion Infectivity Factor (Vif).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

New insights into the formation of HIV-1 reverse transcription initiation complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Advances in the structural understanding of Vif proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Strand transfer events during HIV-1 reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Impact of the terminal bulges of HIV-1 cTAR DNA on its stability and the destabilizing activity of the nucleocapsid protein NCp7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Importance of the proline-rich multimerization domain on the oligomerization and nucleic acid binding properties of HIV-1 Vif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Antiviral potency of APOBEC proteins does not correlate with cytidine deamination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3G inhibits elongation of HIV-1 reverse transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The mechanism of HIV-1 Tat-directed nucleic acid annealing supports its role in reverse transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Vif-deficient HIV reverse transcription complexes (RTCs) are subject to structural changes and mutation of RTC-associated reverse transcription products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

High efficiency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Assembling the human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Assaying RNA chaperone activity in vivo using a novel RNA folding trap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The ubiquitous nature of RNA chaperone proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Flexible nature and specific functions of the HIV-1 nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Cell-free transmission of Vif mutants of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The sor gene of HIV-1 is required for efficient virus transmission in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Identification of a methylated oligoribonucleotide as a potent inhibitor of HIV-1 reverse transcription complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Mechanistic insights into the kinetics of HIV-1 nucleocapsid protein-facilitated tRNA annealing to the primer binding site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

DNA deamination mediates innate immunity to retroviral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Predicting intrinsic disorder in proteins: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Cooperative and Specific Binding of Vif to the 5′ Region of HIV-1 Genomic RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

RNA chaperones and the RNA folding problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Role of vif during packing of the core of HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Nucleocapsid mutations turn HIV-1 into a DNA-containing virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Initiation of HIV Reverse Transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

RNA chaperoning and intrinsic disorder in the core proteins of Flaviviridae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

MDM2 is a novel E3 ligase for HIV-1 Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Global landscape of HIV-human protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Mutational analysis of the HIV-1 auxiliary protein Vif identifies independent domains important for the physical and functional interaction with HIV-1 reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Viral RNA is required for the association of APOBEC3G with human immunodeficiency virus type 1 nucleoprotein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Janus chaperones: assistance of both RNA- and protein-folding by ribosomal proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Structural determinants and mechanism of HIV-1 genome packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Three-dimensional structure of HIV-1 VIF constructed by comparative modeling and the function characterization analyzed by molecular dynamics simulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

HIV-1 accessory proteins--ensuring viral survival in a hostile environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

On the solution conformation and dynamics of the HIV-1 viral infectivity factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The PSIPRED protein structure prediction server

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

A zinc-binding region in Vif binds Cul5 and determines cullin selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The dimerization domain of HIV-1 viral infectivity factor Vif is required to block virion incorporation of APOBEC3G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

When is it time for reverse transcription to start and go?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Properties and functions of the nucleocapsid protein in virus assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Role of Vif in stability of the human immunodeficiency virus type 1 core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Dimerization of retroviral genomic RNAs: structural and functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Dimerization of retroviral RNA genomes: an inseparable pair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

RNA chaperones, RNA annealers and RNA helicases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The C-terminal domain of the HIV-1 Vif protein is natively unfolded in its unbound state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Nucleic acid chaperone activity of retroviral Gag proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Structural disorder in the HIV-1 Vif protein and interaction-dependent gain of structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Proteins with RNA chaperone activity: a world of diverse proteins with a common task-impediment of RNA misfolding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Evidence for a newly discovered cellular anti-HIV-1 phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The HIV 'A' (sor) gene product is essential for virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Twin gradients in APOBEC3 edited HIV-1 DNA reflect the dynamics of lentiviral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Interactions in vivo between the Vif protein of HIV-1 and the precursor (Pr55(GAG)) of the virion nucleocapsid proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Hydrodynamic and functional analysis of HIV-1 Vif oligomerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Molecular cloning of an apolipoprotein B messenger RNA editing protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Structural bases of the annealing of primer tRNA(3Lys) to the HIV-1 viral RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The annealing mechanism of HIV-1 reverse transcription primer onto the viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The role of structural disorder in the function of RNA and protein chaperones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Intrinsically disordered chaperones in plants and animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Protein enhancement of hammerhead ribozyme catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Dissection of the HIV Vif interaction with human E3 ubiquitin ligase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Functional analysis of vif genes derived from various primate immunodeficiency viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Phosphorylation of Vif and its role in HIV-1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

APOBEC3G incorporation into human immunodeficiency virus type 1 particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

7 January 2021

Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

7 January 2021

Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

7 January 2021

Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 Vif mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.06.018

7 January 2021

10.1016/J.VIRUSRES.2012.06.018

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22728817